Extended safety and efficacy data on triple combination therapy using S-1, cisplatin, and paclitaxel in patients with advanced gastric cancer in a multicenter phase II study

被引：0
|
作者：
Iwase, H.
Ina, K.
Goto, H.
Haruta, J.
Kumada, T.
Shinoda, M.
Sugihara, M.
Tsuzuki, T.
Shimada, M.
机构：
[1] Nagoya Med Ctr, Nagoya, Aichi, Japan
[2] Nagoya Mem Hosp, Nagoya, Aichi, Japan
[3] Nagoya Univ, Sch Med, Nagoya, Aichi 466, Japan
[4] Nagoya Daiichi Hosp, Nagoya, Aichi, Japan
[5] Ogaki Municipal Hosp, Ogaki, Japan
[6] Toyota Mem Hosp, Toyota, Japan
[7] Meitetsu Hosp, Nagoya, Aichi, Japan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2010年 / 28卷 / 15期
关键词：
D O I：
10.1200/jco.2010.28.15_suppl.4074
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4074
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Phase II Study of Weekly Paclitaxel and Cisplatin Combination Therapy for Advanced or Recurrent Gastric Cancer
    Nagata, Naoki
    Kimura, Masayuki
    Hirabayashi, Naoki
    Tuburaya, Ahira
    Murata, Teruo
    Kondo, Ken
    Fukuda, Yasuhiko
    Kobayashi, Michiya
    Miyashita, Yumi
    Nakao, Akimasa
    Sahamoto, Junichi
    HEPATO-GASTROENTEROLOGY, 2008, 55 (86-87) : 1846 - 1850
  • [32] Phase I/II study of S-1 combined with cisplatin in patients with advanced gastric cancer
    W Koizumi
    S Tanabe
    K Saigenji
    A Ohtsu
    N Boku
    F Nagashima
    K Shirao
    Y Matsumura
    M Gotoh
    British Journal of Cancer, 2003, 89 : 2207 - 2212
  • [33] A multicenter phase II study of biweekly paclitaxel and S-1 combination chemotherapy for unresectable or recurrent gastric cancer
    Akihiro Nakajo
    Shuichi Hokita
    Sumiya Ishigami
    Futoshi Miyazono
    Tadaaki Etoh
    Masahiro Hamanoue
    Shigeho Maenohara
    Toshimitsu Iwashita
    Hideaki Komatsu
    Kiyoharu Satoh
    Kuniaki Aridome
    Satoshi Morita
    Shoji Natsugoe
    Hiroya Takiuchi
    Shyuji Nakano
    Yoshihiko Maehara
    Junichi Sakamoto
    Takashi Aikou
    Cancer Chemotherapy and Pharmacology, 2008, 62 : 1103 - 1109
  • [34] Phase I/II study of S-1 combined with cisplatin in patients with advanced gastric cancer
    Koizumi, W
    Tanabe, S
    Saigenji, K
    Ohtsu, A
    Boku, N
    Nagashima, F
    Shirao, K
    Matsumura, Y
    Gotoh, M
    BRITISH JOURNAL OF CANCER, 2003, 89 (12) : 2207 - 2212
  • [35] A multicenter phase II study of biweekly paclitaxel and S-1 combination chemotherapy for unresectable or recurrent gastric cancer
    Nakajo, Akihiro
    Hokita, Shuichi
    Ishigami, Sumiya
    Miyazono, Futoshi
    Etoh, Tadaaki
    Hamanoue, Masahiro
    Maenohara, Shigeho
    Iwashita, Toshimitsu
    Komatsu, Hideaki
    Satoh, Kiyoharu
    Aridome, Kuniaki
    Morita, Satoshi
    Natsugoe, Shoji
    Takiuchi, Hiroya
    Nakano, Shyuji
    Maehara, Yoshihiko
    Sakamoto, Junichi
    Aikou, Takashi
    Taxol, Kyushu
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2008, 62 (06) : 1103 - 1109
  • [36] Phase II study of docetaxel and S-1 combination therapy for advanced or recurrent gastric cancer
    Yoshida, Kazuhiro
    Ninomiya, Motoki
    Takakura, Norihisa
    Hirabayashi, Naoki
    Takiyama, Wataru
    Sato, Yuji
    Todo, Satoru
    Terashima, Masanori
    Gotoh, Mitsukazu
    Sakamoto, Jyunnichi
    Nishiyama, Masahiko
    CLINICAL CANCER RESEARCH, 2006, 12 (11) : 3402 - 3407
  • [37] Phase I study of a combination of S-1 and weekly paclitaxel in patients with advanced or recurrent gastric cancer
    Ueda, Y
    Yamagishi, H
    Ichikawa, D
    Morii, J
    Koizumi, K
    Kakihara, N
    Shimotsuma, M
    Takenaka, A
    Yamashita, T
    Kurioka, H
    Nishiyama, M
    Morita, S
    Nakamura, K
    Sakamoto, J
    ONCOLOGY, 2005, 69 (03) : 261 - 268
  • [38] A phase I study of sorafenib in combination with S-1 plus cisplatin in patients with advanced gastric cancer
    Yasuhide Yamada
    Naomi Kiyota
    Nozomu Fuse
    Ken Kato
    Hironobu Minami
    Kensei Hashizume
    Yoshihiro Kuroki
    Yuichiro Ito
    Atsushi Ohtsu
    Gastric Cancer, 2014, 17 : 161 - 172
  • [39] A phase I study of sorafenib in combination with S-1 plus cisplatin in patients with advanced gastric cancer
    Yamada, Yasuhide
    Kiyota, Naomi
    Fuse, Nozomu
    Kato, Ken
    Minami, Hironobu
    Hashizume, Kensei
    Kuroki, Yoshihiro
    Ito, Yuichiro
    Ohtsu, Atsushi
    GASTRIC CANCER, 2014, 17 (01) : 161 - 172
  • [40] Phase II study of S-1 in combination with paclitaxel as a first-line treatment for patients with advanced/recurrent gastric cancer
    Toh, U.
    Yamana, H.
    Koufuji, K.
    Mine, T.
    Aoyagi, K.
    Miyagi, M.
    Imaizumi, T.
    Shirouzu, K.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
12345